Product Information
VERAPAMIL 40 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1126 per EA under NDC 62135074390. Its NADAC has been published 144 times since Jan 3, 2024.
FDA first approved this application on Apr 5, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Chartwell RX LLCNDC
62135074390
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071881FDA Approved
4/5/1988
TE Code
AB
On Market Since
10/15/2015
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL 40 MG TABLET has been published 144 times since Jan 3, 2024, and over the history we have for it it has declined 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1126 per EA |
|---|---|
| All-time high | $0.1381 (Apr 10, 2024) |
| All-time low | $0.1060 (Jul 17, 2024) |
| 52-week high | $0.1330 |
| 52-week low | $0.1126 |
| Median price | $0.1241 |
| Average price | $0.1240 |
| Largest weekly change | +24.7% (Aug 21, 2024) |
| Weeks tracked | 144 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
VERAPAMIL HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VERAPAMIL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 40 MG TABLET, manufactured by Chartwell RX LLC, is $0.1126 per EA (NDC 62135074390), effective Sep 30, 2026.
How has the price of VERAPAMIL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL 40 MG TABLET has declined 15.9%. It has been tracked across 144 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for VERAPAMIL 40 MG TABLET?
Since Jan 3, 2024, the NADAC for VERAPAMIL 40 MG TABLET has ranged from a low of $0.1060 (Jul 17, 2024) to a high of $0.1381 (Apr 10, 2024), with a median of $0.1241 per EA.
Are there cheaper alternatives to VERAPAMIL 40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL 40 MG TABLET?
VERAPAMIL 40 MG TABLET (NDC 62135074390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.